FIELD: biotechnologies.
SUBSTANCE: invention relates to derivatives of aminopyrazol with the formula of , where A, E, R1 and R2 have values specified in the invention claims, and to their pharmaceutically acceptable salts. Compounds of the formula (I) are agonists of the ALX receptor. Besides, the invention relates to a pharmaceutical composition on the basis of the compound of the formula (I) or its pharmaceutically acceptable salt and to application of these compounds for production of a medicinal agent for prevention or treatment of a disease selected from inflammatory diseases, wheezing diseases, allergic states, HIV-mediated retrovirus infections, cardiovascular diseases, neuroinflammations, neurological disorders, pain, prion-mediated diseases and amiloid-mediated diseases; and for modulation of immune responses.
EFFECT: higher efficiency of compound application.
23 cl, 1 tbl, 466 ex
Title | Year | Author | Number |
---|---|---|---|
AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS | 2008 |
|
RU2492167C2 |
FLUORINATED AMINOTRIAZOLE DERIVATIVES | 2010 |
|
RU2544862C2 |
AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
NOVEL DUAL ACTING ATI AND ETA RECEPTOR ANTAGONISTS (DARA) | 2007 |
|
RU2425833C2 |
HETEROBICYCLIC CARBOXAMIDES AS KINASE INHIBITORS | 2007 |
|
RU2436785C2 |
INDOLYL DERIVATIVES AS LIVER X-RECEPTOR MODULATORS | 2005 |
|
RU2368612C2 |
DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
INDOLE-2-CARBOXAMIDES AS INHIBITORS OF FACTOR Xa AND/OR VIIa, MEDICINAL AGENT BASED ON THEREOF AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2299881C2 |
1,3-DISUBSTITUTED 4-METHYL-1H-PYRROL-2-CARBOXAMIDES AND USE THEREOF FOR PREPARING DRUGS | 2007 |
|
RU2463294C2 |
Authors
Dates
2013-08-10—Published
2008-12-12—Filed